Explore BIG CHANGE reporting on AI-led research: what changed, how it works and why it matters.
OpenAI has acquired Orchestra Bio and plans to bring its drug-program coordination platform together with Rosalind. A combined product and faster treatments remain goals, not demonstrated results.
Anthropic reports that 17 of 211 selected protein designs met its toxin-binding criteria. The study did not test whether they neutralise venom in cells or animals.
A new computational method couples RNA sequence and base orientation during inverse folding. Its benchmark gains rely on predicted structures and remain untested in the lab.
Google's biotech reference design separates agent planning, GPU scientific computation and access controls. The combined workflow remains an unmeasured proposal.
An author-reported benchmark follows AI agents through dependent bioinformatics tasks. Scores fall on later steps, while feedback improves results under limits.
An Anthropic and Harvard preprint uses Claude to propose quantum circuits and a separate evaluator to check them. Seven of eight tasks show lower estimated gate and qubit counts under the paper's comparisons.
Danaher and NVIDIA plan integrations across scientific instruments, AI models and data analysis. The announcement names computing tools but leaves products, access and measured results unspecified.
Anthropic says Claude helped reconstruct how several NIST and ANSI curve seeds were generated. Its code matches published values, while some base points and selection choices remain unexplained.
OpenAI is taking applications from eligible U.S. university labs for up to 30 sponsored ChatGPT Business seats and GPT-Rosalind access, subject to verification, approval and activation.
Simons, Anthropic and OpenAI have committed $15 million in combined funding and resources. The foundation will manage awards for mathematicians to examine AI-assisted work and develop standards.
Google traced one peptide candidate through sequence, structure and genomic checks with Antigravity. Its predicted activity still awaits lab results.
CERN and Mistral signed a statement of intent for AI in physics. Existing CMS reconstruction work predates the proposed foundation-model partnership.
QuEra reports 695 on-target recoveries in 700 testbed trials of a deterministic laser-relocking script developed with Claude. Its separate tuning workflow still uses AI.
TESS has an active target for TIC 4206066. New observations will test a researcher's preregistered transit predictions, while the planet interpretation remains unconfirmed.
A Sakana AI preprint reports 73.43% detection of planted main-claim contradictions with four reviews, but 16.11% exact matches to errors in withdrawn papers. The results test a narrower task than reliable peer review.
Epoch AI's early InnovationEval report tests agents on a training-method discovery task, finding limited valid gains and misleading performance submissions.
A study screened 12,000 designed CD20 binders in CAR-T cells. It found 707 pooled growth hits; four of ten individually tested showed significant specific target-cell killing.
A new paper ranks candidate explanations by statistical certification, fit with background knowledge and simplicity, then tests how the approach behaves in synthetic and dataset-based tasks.
